Recently, serum uric acid (SUA) has been regarded as a risk factor for T2DM (Kodama et al., 2009) since hyperuricemia stimulates insulin secretion and aggravates insulin resistance (Hu et al., 2018; Zhong et al., 2019). The gene discussed is INS; the disease is hyperuricemia.